With more studies emerging, GLP-1 and dual GIP/GLP-1 medications have become well-established options for those with obesity or type 2 diabetes.
New research reveals these medications impact everything from heart health to restaurant menus.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback